New Delhi: The good thing for the world that is battling the Covid-19 epidemic is that it has many vaccine options. Pfizer, Oxford-Estrogenica, Indo-Biotech vaccine has been started. There are expectations from others, including Moderna, Novamax and Russia's Vaccine Sputnik V, which could be used soon. These vaccines are produced from weak or microscopic particles of coronavirus, which can lead to its end.
KoviShield and Sputnik V: According to the information found, Oxford-AstraZeneca's CoviShield and Russian Vaccine are working on a technique of Sputnik. Weak fractions of Covid have been used to prepare them, so that there is no fear of infection. Due to the viral present in both these vaccines, they cannot expand in the body. It is also being said that this can only prepare the body to fight the Covid-19 virus. In future, these works can be started whenever the body comes in relation to the virus. Adenovirus has been used in the vaccine, which is the cause of common cold in chimpanzee.
Inactivated Virus Vaccine Covaxin: While Covaxin is the country's first indigenous vaccine, Hyderabad-based company Bharat-Biotech has created a collaboration with ICMR. Passive infection has been used to make it, so that there is no fear of infection growing at all. Another special feature of this vaccine is that it can be applied to people with weak immunity. Some vaccines of polio, measles are also on the same lines. The immunity will be weak with this vaccine, but such molecules will be prepared so that the body can easily fight infection in future.
Also Read-
KCR will review the start of the school at an important meeting on January 11th
